$1.96
-0.05 (-2.49%)
Open$2.01
Previous Close$2.01
Day High$2.05
Day Low$1.96
52W High$3.95
52W Low$1.56
Volume—
Avg Volume39.7K
Market Cap78.71M
P/E Ratio—
EPS$-0.65
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,629.1% upside
Current
$1.96
$1.96
Target
$33.89
$33.89
$29.33
$33.89 avg
$54.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 68.3K | 102.0K | 14.53M |
| Net Income | -26,901,622 | -36,168,897 | -1,603,701 |
| Profit Margin | -39,417.3% | -37,446.4% | -11.0% |
| EBITDA | -29,965,652 | -42,526,694 | -1,702,906 |
| Free Cash Flow | — | — | -884,905 |
| Rev Growth | -33.1% | -33.1% | +22.5% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |